Business Wire

Invicro LLC Joins Accenture’s INTIENT™ Network to Help Advance Innovation in Drug Discovery and Scientific Research

Share

Today, Invicro LLC, a Konica Minolta Company, has joined Accenture’s open partner ecosystem—the INTIENT™ Network—which is designed to help solution providers, software vendors and life sciences companies’ team more effectively to accelerate drug discovery and improve patient outcomes. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.

The INTIENT Network is an integral part of INTIENT Research, Accenture’s cloud-based informatics suite that is focused on improving productivity, efficiency and innovation in the drug discovery process. Accenture is currently working with a select number of independent software vendors and organizations, including Invicro, to integrate their technology and content into the INTIENT platform.

Through the INTIENT Network, research scientists can access Invicro’s industry-leading imaging software platforms, iPACS® and VivoQuant®, that help transform the way translational medicine research is conducted. Invicro joining the network contributes to a robust ecosystem—one that offers the most advanced, cloud-based informatics solutions to help accelerate precision medicine studies across all therapeutic areas.

“By providing access to Invicro’s novel software solutions, researchers will easily gain insights from complex biological data at each drug discovery and development phase,” stated Mr. Chris Fuller, Vice President of Software for Invicro. “The advanced and collaborative capabilities offered by Invicro and Accenture will improve operational efficiencies and help streamline drug discovery efforts by using a data-driven approach.”

Invicro’s capabilities will be available to life sciences companies within a common informatics framework that handles core infrastructure requirements such as data ingestion and cleansing, security and IP management, request management workflow, enterprise search, data governance, and collaboration environments.

“Imaging data is enabling some incredible opportunities in early drug discovery, yet there remain challenges around the effective image management, interpretation, and sharing,” said Joe Donahue, managing director, Accenture Life Sciences. “I look forward to working closely with Invicro to leverage their capabilities to help address these challenges which will, ultimately, lead to better outcomes for patients.”

About Invicro
Headquartered in Boston, MA, Invicro was founded in 2008 and today has offices, laboratories and clinics around the world, from coast-to-coast within the United States, to Europe and Asia that support leading pharmaceutical and biotechnology companies and top research universities. Invicro’s multi-disciplinary team provides solutions to help enhance the discovery and development of life-changing drugs across all stages of the drug development pipeline (Phase 0-IV), leveraging all imaging modalities within a broad scope of therapeutic areas, including neurology, oncology, cardiology, and pulmonary. Invicro’s quantitative biomarker services, advanced analytics tools, and clinical operational services are backed by their industry-leading software informatics platforms, VivoQuant® and iPACS®.

Invicro is a Konica Minolta company and part of their precision medicine initiative, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. Along with their sister company Ambry Genetics, Invicro develops and leverages the latest approaches in quantitative biomarkers including imaging, quantitative pathology and genomics. Visit www.invicro.com for more information

About Konica Minolta
Konica Minolta, Inc. (Konica Minolta) is a global digital technology company with core strengths in imaging and data analysis, optics, materials, and nano-fabrication. Through innovation, Konica Minolta creates products and digital solutions for the betterment of business and society—today and for generations to come. Across its Business Technologies, Healthcare, and Industrial-facing businesses, the company aspires to be an Integral Value Provider that applies the full range of its expertise to offer comprehensive solutions to the customer’s most pressing problems, works with the partners to ensure the solutions are sustainable, anticipates and addresses tomorrow’s issues, and tailors each solution to meet the unique and specific needs of its valued customers. Leveraging these capabilities, Konica Minolta contributes to productivity improvement and workflow change for its customers and provides leading-edge service solutions in the IoT era. Headquartered in Tokyo and with operations in more than 50 countries, Konica Minolta has more than 43,000 employees serving approximately two million customers in over 150 countries. Konica Minolta is listed on the Tokyo Stock Exchange, (TSE4902). For further information, visit: https://www.konicaminolta.com/.

Contact information

Amanda Harrell
VP, Global Marketing
media@invicro.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Parimatch Makes Statement of Intent for Newly Legalised Ukraine Gambling Industry11.8.2020 16:38:00 EESTPress release

Following the signing of Bill No. 2285-d by President Volodymyr Zelenskyi to legalise the gambling industry in Ukraine, Parimatch, the international betting and technology company, has confirmed it will be bidding for the new operating licences in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200811005562/en/ Parimatch Makes Statement of Intent for Newly Legalised Ukraine Gambling Industry (Graphic: Business Wire) Parimatch was founded in Ukraine in 1994 and was amongst the first bookmakers in the CIS region to transition into a digital betting platform. Today, Parimatch has expanded internationally to become a global betting and technology brand. The company now looks to build on its heritage to become the largest and most innovative operator in its home market. Commenting on today’s signing, Sergey Portnov, CEO of Parimatch said: “I would firstly like to congratulate President Zelenskyi for delivering on his

Andersen Global Enhances Africa Platform With the Addition of Law Firm in Gabon11.8.2020 16:30:00 EESTPress release

Further strengthening its global platform and adding breadth to its regional footprint in Central Africa, Andersen Global announces its expansion into Gabon through a Collaboration Agreement with Libreville-based Business & Law Consulting (B & Law Consulting). The law firm, founded in 2017, is composed of more than 10 professionals who advise businesses in the areas of contract, corporate, commercial, tax, international trade, employments and general business law. “We are devoted to providing our clients with best-in-class solutions and maintain transparency and independence when handling client matters,” Managing Partner Khadidjatou Boussougou said. “Collaborating with Andersen Global is a great opportunity for us to continue to build our momentum and improve the quality of the services offered to our clients at an international level.” Andersen Global Chairman and Andersen CEO Mark Vorsatz said, “I am impressed with the level of efficiency and enthusiasm that B & Law Consulting demon

Immervision Introduces Wide-Angle Distortion Correction Algorithms with Face and Body Protection for Videos on Smartphones11.8.2020 16:00:00 EESTPress release

Immervision, the Montreal-based developer and licensor of patented, wide-angle optics and imaging technology, today announced new real-time video distortion correction algorithms making videos the same as we see with our human eyes. The algorithms are available for mobile OEMs to license now from Immervision’s exclusive distribution partner CEVA. The addition of these new algorithms to Immervision’s broad imaging processing software portfolio will enhance the differentiation OEMs can deliver in next-generation phones. In phones, the wider field of view (FOV) creates more apparent distortion. The algorithms from Immervision fix stretched bodies, curved lines, object and face proportions in real-time adjusting to the scene without any postprocessing required - all in one solution. Immervision provides different levels of correction, varied projections and real-time adaptation to the scene and supports OEMs creating a differentiated experience. “Video recording on phones is skyrocketing a

K2View Raises $28 Million to Accelerate Rapid Expansion in the DataOps Market11.8.2020 15:00:00 EESTPress release

K2View, a leading provider of real-time DataOps solutions, today announced its $28 million funding round, which will accelerate the company’s growth and expansion in the emerging DataOps market. Forestay Capital led the round along with funding from Genesis Partners. It comes on the heels of rapid growth that saw over 75 percent CAGR in revenue, with a strong first half of 2020. This investment will be used to support the company’s go-to-market strategy as it continues its expansion in markets ripe for transformation with DataOps, such as telecom, financial services, healthcare, insurance, logistics and more. “The fastest method to achieve true agility and exceptional customer experience is moving away from 30-plus years of application-driven enterprise into the data-driven enterprise. This is a critical component for digital transformation and a massive opportunity for us,” said Achi Rotem, CEO and co-founder of K2View. “As we look to the next stage of our growth, our vision is to con

ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-1911.8.2020 15:00:00 EESTPress release

ANA Therapeutics, a Silicon Valley-based biotech startup, and Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candidate, ANA001 (niclosamide capsules), which they are developing as a potential treatment for COVID-19. As part of the collaboration, Quotient will scale up the capsule formulation, characterize and optimize the manufacturing process and ensure continuity of drug product through clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200811005106/en/ Laboratory experiments have shown niclosamide stops SARS-CoV-2 (the virus that causes COVID-19) from replicating, making it a promising candidate for reducing the spread of COVID-19. Niclosamide was previously approved by the FDA as a treatment for tapeworm and although not currently marketed in the U.S., it is on the World Hea

Visa Expands Commitment to Sustainability Through Inaugural $500 Million Green Bond Issuance and Appointment of Chief Sustainability Officer Role11.8.2020 14:00:00 EESTPress release

Visa (NYSE: V), a leading global payments technology company, today announced that yesterday it successfully priced its inaugural green bond offering, totaling $500 million, paying a semi-annual coupon of 0.75% and maturing August 15, 2027. The green bond, believed to be the first issued by a digital payments network, will be used to help advance the company’s commitment to environmental sustainability and a sustainable payments ecosystem. In support of that commitment and in addition to its inaugural green bond, Visa is also announcing the appointment of its first chief sustainability officer, Douglas Sabo. “At Visa, we see a responsibility and an opportunity to use the power of our network to drive broad shifts toward a sustainable future,” said Al Kelly, chairman and chief executive officer of Visa Inc. “Our green bond offering will help us accelerate the transformation of our infrastructure and operations to reach our environmental goals. This commitment extends to appointing Visa’

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom